Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized treatment for elderly EGFR wild-type advanced NSCLC
ChiCTR-TRC-10001620Phase 2Completed
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of vinorelbine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoint: progression-free survival. Started Jun 2010; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-10001620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001620.